全球疼痛管理市场（2023-2030）：按应用（神经病变疼痛、癌症疼痛）和配销通路（线上药房、零售药房）分類的规模、份额、成长分析和预测

根据预测，全球疼痛管理市场规模将从2021年的721亿美元成长到2030年的1,053.2亿美元，而2022年为752亿美元，预测期内年复合成长率为4.3%。

由于关节炎、癌痛、神经性疼痛和神经病变疾病等慢性疼痛疾病的盛行率不断上升，全球疼痛管理市场正在显着扩大。慢性疼痛患者的迅速增加推动了对有效止痛解决方案的需求。新型药物、医疗设备和微创手术等疼痛管理技术的进步，以及神经调节和标靶药物传递系统等先进技术的整合，正在扩大有效治疗选择的范围。

然而，挑战也存在，包括对阿片类药物滥用和成瘾的担忧，促使加强法规并转向非阿片替代来治疗疼痛。因此，医疗保健提供者和製药公司面临着平衡缓解疼痛的需求与潜在风险的挑战。

本报告调查了全球疼痛管理市场，并提供了市场概况、市场各种影响因素分析、技术和创新趋势、法律制度、市场规模趋势和预测，以及按各个细分市场和地区进行的细分。竞争形势、主要企业概况等

目录

• 执行摘要
• 调查方法
• 母市场分析
  • 市场概况
  • 市场规模
  • 市场动态
    • 促进因素
    • 机会
    • 抑制因素
    • 任务
• 关键市场洞察
  • 技术分析
  • 价格分析
  • 供应链分析
  • 价值链分析
  • 市场生态系统
  • 智慧财产权分析
  • 贸易分析
  • 启动分析
  • 原料分析
  • 创新矩阵
  • 研发线产品分析
  • 总体经济指标
  • 重点投资分析
  • 关键成功因素
  • 竞争程度
  • 市场动态及展望
    • 市场动态
      • 促进因素
      • 机会
      • 抑制因素
      • 任务
  • 法规状况
  • 波特的分析
  • Skyquest 对未来颠覆的独家见解
• 全球疼痛管理市场：依应用分类
  • 市场概况
  • 神经性疼痛
  • 癌症痛
  • 脸部疼痛/偏头痛
  • 肌肉骨骼疼痛
  • 其他的
• 全球疼痛管理市场：按配销通路
  • 市场概况
  • 网路药房
  • 零售药房
  • 医院药房
• 全球疼痛管理市场：按地区
  • 市场概况
  • 北美洲
  • 欧洲
  • 亚太地区
  • 拉丁美洲
  • 中东/非洲
• 竞争形势
  • 前5名企业对比
  • 主要企业市场地位
  • 主要企业的招募策略
  • 关键成功策略
  • 近期市集活动
  • 主要企业市场占有率
• 主要企业简介
  • Johnson & Johnson
  • Pfizer Inc.
  • Novartis International AG
  • Eli Lilly and Company
  • GlaxoSmithKline PLC
  • AbbVie Inc.
  • AstraZeneca PLC
  • Bayer AG
  • Merck & Co., Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Sanofi SA
  • Bristol Myers Squibb Company
  • Medtronic PLC
  • Abbott Laboratories
  • Boston Scientific Corporation
  • St. Jude Medical, Inc.
  • Stryker Corporation
  • Cardinal Health, Inc.
  • Halyard Health (O&M Halyard)
  • Mallinckrodt Pharmaceuticals

Global Pain Management Market size was valued at USD 72.1 Billion in 2021 and is poised to grow from USD 75.20 Billion in 2022 to USD 105.32 Billion by 2030, at a CAGR of 4.3% during the forecast period (2023-2030).

The global pain management market has experienced substantial expansion due to the rising prevalence of chronic pain conditions, including arthritis, cancer pain, neuropathic pain, and musculoskeletal disorders. This surge in chronic pain cases has driven demand for effective pain relief solutions. Advancements in pain management technologies, such as novel pharmaceuticals, medical devices, and minimally invasive procedures, along with the integration of advanced technologies like neuromodulation and targeted drug delivery systems, have broadened the range of effective treatment options. However, challenges exist, including concerns about opioid abuse and addiction, which have prompted stricter regulations and a shift toward non-opioid alternatives for pain management, thereby presenting healthcare providers and pharmaceutical companies with the task of balancing pain relief needs with potential risks.

Top-down and bottom-up approaches were used to estimate and validate the size of the global pain management market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined by using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Segments covered in this report

The global pain management market is segmented on the basis of application, distribution channel, and region. By application, the market is segmented into neuropathic pain, cancer pain, facial pain and migraine, musculoskeletal pain, and other applications. By distribution channel, the market is segmented into online pharmacy, retail pharmacy, and hospital pharmacy. By region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Drivers:

Increasing Awareness and Focus on Pain Management

A heightened understanding of pain's profound influence on people's well-being is prompting healthcare providers, patients, and policymakers to prioritize pain management, resulting in intensified research, education, and enhanced access to efficient pain relief. This emphasis on patient-centered care and better pain management outcomes is propelling the market forward.

Rising Geriatric Population

The pain management market is being notably influenced by the aging population, given that older adults are at a higher risk of experiencing chronic pain issues like osteoarthritis and neuropathic pain. As the world experiences a growing trend of aging demographics, the need for pain management solutions is on the rise, as elderly individuals actively seek efficient ways to alleviate pain and sustain their overall well-being and autonomy.

Restraints:

High Cost of Pain Management Treatments

The growth of the market for pain management treatments can be impeded by the high costs associated with advanced procedures and devices, which may hinder access for specific patient groups, especially in low-income regions or countries with limited healthcare resources. The expenses related to medications, surgical interventions, and specialized therapies pose a significant barrier to broader market expansion.

Regulatory and Reimbursement Challenges

The pain management industry is influenced by regulatory stipulations and reimbursement obstacles that can impede its expansion. Regulatory factors, such as constraints on opioid prescription and medical device regulations, play a pivotal role in shaping the accessibility of pain management solutions. Additionally, reimbursement policies and constraints can impact the adoption and utilization of specific pain management treatments.

Market Trends:

The current trend in pain management involves a growing focus on multimodal, personalized approaches that encompass a range of therapies and interventions to address pain comprehensively. This includes a combination of pharmaceutical treatments, non-pharmacological therapies, physical therapy, psychological interventions, and lifestyle modifications, all tailored to the specific needs of each patient, considering factors like the pain's underlying cause, comorbidities, and patient preferences. Additionally, minimally invasive procedures for pain relief, such as nerve blocks, radiofrequency ablation, and spinal cord stimulation, are becoming increasingly popular due to their targeted pain relief, reduced invasiveness, shorter recovery periods, and potential for fewer side effects when compared to traditional surgical methods, driven by advancements in medical technology and healthcare professionals' growing expertise.

Table of Contents

• Executive Summary
  • Market Overview
  • Wheel of Fortune
• Research Methodology
  • Information Procurement
  • Secondary & Primary Data Sources
  • Market Size Estimation
  • Market Assumptions & Limitations
• Parent Market Analysis
  • Market Overview
  • Market Size
  • Market Dynamics
• Drivers
• Opportunities
• Restraints
• Challenges
• Key Market Insights
  • Technology Analysis
  • Pricing Analysis
  • Supply Chain Analysis
  • Value Chain Analysis
  • Ecosystem of the Market
  • IP Analysis
  • Trade Analysis
  • Startup Analysis
  • Raw Material Analysis
  • Innovation Matrix
  • Pipeline Product Analysis
  • Macroeconomic Indicators
  • Top Investment Analysis
  • Key Success Factor
  • Degree of Competition
• Market Dynamics & Outlook
  • Market Dynamics
• Drivers
• Opportunities
• Restraints
• Challenges
  • Regulatory Landscape
  • Porters Analysis
• Competitive rivalry
• Threat of Substitute Products
• Bargaining Power of Buyers
• Threat of New Entrants
• Bargaining Power of Suppliers
  • Skyquest Special Insights on Future Disruptions
• Political Impact
• Economic Impact
• Social Impact
• Technical Impact
• Environmental Impact
• Legal Impact
• Global Pain Management Market by Application
  • Market Overview
  • Neuropathic pain
  • cancer pain
  • facial pain and migraine
  • musculoskeletal pain
  • and other applications
• Global Pain Management Market by Distribution Channel
  • Market Overview
  • Online pharmacy
  • retail pharmacy
  • and hospital pharmacy
• Global Pain Management Market Size by Region
  • Market Overview
  • North America
• USA
• Canada
  • Europe
• Germany
• Spain
• France
• UK
• Rest of Europe
  • Asia Pacific
• China
• India
• Japan
• South Korea
• Rest of Asia-Pacific
  • Latin America
• Brazil
• Rest of Latin America
  • Middle East & Africa (MEA)
• GCC Countries
• South Africa
• Rest of MEA
• Competitive Landscape
  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2021
  • Strategies Adopted by Key Market Players
  • Top Winning Strategies
• By Development
• By Company
• By Year
  • Recent Activities in the Market
  • Key Companies Market Share (%), 2021
• Key Company Profiles
  • Johnson & Johnson - US
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Pfizer Inc. - US
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Novartis International AG - Switzerland
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Eli Lilly and Company - US
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • GlaxoSmithKline PLC - United Kingdom
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • AbbVie Inc. - US
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • AstraZeneca PLC - United Kingdom
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Bayer AG - Germany
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Merck & Co., Inc. - US
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Teva Pharmaceutical Industries Ltd. - Israel
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Sanofi S.A. - France
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Bristol Myers Squibb Company - US
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Medtronic PLC - Ireland
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Abbott Laboratories - US
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Boston Scientific Corporation - US
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • St. Jude Medical, Inc. (Abbott) - US
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Stryker Corporation - US
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Cardinal Health, Inc. - US
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Halyard Health (O&M Halyard) - US
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Mallinckrodt Pharmaceuticals - US
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments